Results 51 to 60 of about 22,945 (169)

Budget impact of implementing universal Plasmodium NAT screening in the blood transfusion system in the US

open access: yesTransfusion, EarlyView.
Abstract Background Blood donor deferral for malaria risk relies exclusively on responses to self‐reported questionnaires. This study evaluated the economic impact of introducing Plasmodium nucleic acid testing (NAT) as a universal screening strategy in the United States.
Cristina Coll‐Ortega   +3 more
wiley   +1 more source

Robust functional response to WNV by NK cells from asymptomatic and symptomatic WNV subjects.

open access: yes, 2017
PBMCs from asymptomatic (n = 10) and symptomatic (n = 12) WNV subjects were incubated with medium alone (mock) or infected with WNV (MOI = 1) for 24 h.
Anna Malawista (3779173)   +7 more
core   +1 more source

In vitro and in vivo characterization of a novel West Nile virus lineage 2 strain

open access: yesnpj Viruses
Over recent decades, West Nile virus (WNV) has continued to expand its geographical range, emerging in previously non-endemic areas, including northern Europe.
Imke Visser   +6 more
doaj   +1 more source

Differential Virulence and Pathogenesis of West Nile Viruses

open access: yesViruses, 2013
West Nile virus (WNV) is a neurotropic flavivirus that cycles between mosquitoes and birds but that can also infect humans, horses, and other vertebrate animals. In most humans, WNV infection remains subclinical.
Emilie Donadieu   +5 more
doaj   +1 more source

Specific infectivity of WNV replication complex mutants.

open access: yes, 2015
WNV RNA (viral particles) and infectious virus (pfu) were quantified following 1-step growth on mosquito (CxT) or vertebrate (BHK) cell culture and specific infectivity (particle/pfu) was compared among WNV-IC, WNV V793I/G806R and WNV T248I.
Jamie J. Arnold (120696)   +7 more
core   +1 more source

Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells [PDF]

open access: yes, 2004
No specific vaccine for West Nile virus (WNV) is currently available for human use. In the present study, we describe the generation of WNV-like particles (WNV-LPs) in insect cells by use of recombinant baculoviruses expressing the WNV structural ...
Ashok, Mundrigi   +6 more
core   +1 more source

West Nile virus in overwintering mosquitoes, central Europe

open access: yesParasites & Vectors, 2017
Background West Nile virus (WNV) is currently the most important mosquito-borne pathogen spreading in Europe. Data on overwintering of WNV in mosquitoes are crucial for understanding WNV circulation in Europe; nonetheless, such data were not available so
Ivo Rudolf   +10 more
doaj   +1 more source

Confidence Intervals for a Proportion Estimated From Pooled Samples Based on Firth's Corrected Score

open access: yesBiometrical Journal, Volume 68, Issue 5, October 2026.
ABSTRACT Interval estimation of a proportion estimated from testing of pooled samples has been studied by a variety of researchers, who have examined both exact and asymptotic methods. Recent work in point estimation has seen the use of Firth's correction to maximum likelihood estimation to reduce bias effectively. We consider the Firth‐corrected score
Brad J. Biggerstaff, Graham Hepworth
wiley   +1 more source

WNV dissemination per tissue.

open access: yes, 2014
Summary of WNV dissemination per tissue as determined by plaque assay and qRT-PCR.WNV dissemination per tissue.
Terry L. Juelich (180664)   +9 more
core   +1 more source

IL-10 signaling blockade controls murine West Nile virus infection.

open access: yesPLoS Pathogens, 2009
West Nile virus (WNV), a mosquito-borne single-stranded RNA flavivirus, can cause significant human morbidity and mortality. Our data show that interleukin-10 (IL-10) is dramatically elevated both in vitro and in vivo following WNV infection.
Fengwei Bai   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy